Ikeda, K., Ueda, K., Sano, T., Ogawa, K., Ikezoe, T., Hashimoto, Y., . . . Takeishi, Y. (2017). The Amelioration of Myelofibrosis with Thrombocytopenia by a JAK1/2 Inhibitor, Ruxolitinib, in a Post-polycythemia Vera Myelofibrosis Patient with a JAK2 Exon 12 Mutation. Intern Med.
Citación estilo ChicagoIkeda, Kazuhiko, et al. "The Amelioration of Myelofibrosis With Thrombocytopenia By a JAK1/2 Inhibitor, Ruxolitinib, in a Post-polycythemia Vera Myelofibrosis Patient With a JAK2 Exon 12 Mutation." Intern Med 2017.
Cita MLAIkeda, Kazuhiko, et al. "The Amelioration of Myelofibrosis With Thrombocytopenia By a JAK1/2 Inhibitor, Ruxolitinib, in a Post-polycythemia Vera Myelofibrosis Patient With a JAK2 Exon 12 Mutation." Intern Med 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.